Cargando…

Extensively Drug-Resistant Salmonella enterica serovar Typhi in Pediatric population during CoVID-19 Pandemic

PURPOSE: The Extensively Drug-resistant (XDR) Salmonella isolates exhibiting resistance to the first line and the second-line antibiotic options are presently a grave public health concern in Pakistan. Here, we report the first large-scale emergence and spread of an XDR S. Typhi in Peshawar, Pakista...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, M., Tu-Zahra, F., Gul, A., Saleem, M.Z., Riaz, M., Gul, W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884783/
http://dx.doi.org/10.1016/j.ijid.2021.12.010
_version_ 1784660241060724736
author Khan, M.
Tu-Zahra, F.
Gul, A.
Saleem, M.Z.
Riaz, M.
Gul, W.
author_facet Khan, M.
Tu-Zahra, F.
Gul, A.
Saleem, M.Z.
Riaz, M.
Gul, W.
author_sort Khan, M.
collection PubMed
description PURPOSE: The Extensively Drug-resistant (XDR) Salmonella isolates exhibiting resistance to the first line and the second-line antibiotic options are presently a grave public health concern in Pakistan. Here, we report the first large-scale emergence and spread of an XDR S. Typhi in Peshawar, Pakistan during Coronavirus disease (CoVID-19) pandemic. Initially XDR typhoid cases were reported during post rainy season but now the disease has become endemic during winter months. METHODS & MATERIALS: From December 2020 till January 2021, we reported the high level of emerging resistance to different groups of antibiotics among Salmonella isolates from paediatric age group with enteric fever. A total of 548 blood cultures from symptomatic patients were submitted to Microbiology section of Pathology Laboratory, Rehman Medical Institute, Peshawar. All samples were incubated in BACTEC 9240 and processed according to standard guidelines (sub-cultured on Blood and MacConkey's agar and non-lactose fermenting colonies were biochemically tested for Salmonella typhi and confirmed by Salmonella specific anti-sera. Demographic data including age, gender, address and clinical features were also recorded. RESULTS: Salmonella Typhi was isolated in 71 and 548 blood samples during December 2020 and January 2021, out of which 66 (92.9%) and 5% (7%) were MDR, respectively. All isolates revealed high level of resistance to co-trimaxazole (93%) and complete resistance to chloramphenicol (100%), ampicillin (100%), ciprofloxacin (100%), ceftriaxone (100%), cefixime (100%). All XDR typhoid isolates were sensitive to azithromycin and carbapenems. The children under 15 years’ age (88%) has a significantly high prevalence among children as compared to adults (p=0.0016), males (76%) were affected more than females (24%). CONCLUSION: The emergence of XDR S. typhi with high level of resistance is quite alarming. With inadequate treatments options, the present situation calls for immediate effective preventive measures including food and water safety, improved sanitation, public awareness sessions and typhoid vaccination campaigns.
format Online
Article
Text
id pubmed-8884783
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-88847832022-03-01 Extensively Drug-Resistant Salmonella enterica serovar Typhi in Pediatric population during CoVID-19 Pandemic Khan, M. Tu-Zahra, F. Gul, A. Saleem, M.Z. Riaz, M. Gul, W. Int J Infect Dis Op01.09 (1017) PURPOSE: The Extensively Drug-resistant (XDR) Salmonella isolates exhibiting resistance to the first line and the second-line antibiotic options are presently a grave public health concern in Pakistan. Here, we report the first large-scale emergence and spread of an XDR S. Typhi in Peshawar, Pakistan during Coronavirus disease (CoVID-19) pandemic. Initially XDR typhoid cases were reported during post rainy season but now the disease has become endemic during winter months. METHODS & MATERIALS: From December 2020 till January 2021, we reported the high level of emerging resistance to different groups of antibiotics among Salmonella isolates from paediatric age group with enteric fever. A total of 548 blood cultures from symptomatic patients were submitted to Microbiology section of Pathology Laboratory, Rehman Medical Institute, Peshawar. All samples were incubated in BACTEC 9240 and processed according to standard guidelines (sub-cultured on Blood and MacConkey's agar and non-lactose fermenting colonies were biochemically tested for Salmonella typhi and confirmed by Salmonella specific anti-sera. Demographic data including age, gender, address and clinical features were also recorded. RESULTS: Salmonella Typhi was isolated in 71 and 548 blood samples during December 2020 and January 2021, out of which 66 (92.9%) and 5% (7%) were MDR, respectively. All isolates revealed high level of resistance to co-trimaxazole (93%) and complete resistance to chloramphenicol (100%), ampicillin (100%), ciprofloxacin (100%), ceftriaxone (100%), cefixime (100%). All XDR typhoid isolates were sensitive to azithromycin and carbapenems. The children under 15 years’ age (88%) has a significantly high prevalence among children as compared to adults (p=0.0016), males (76%) were affected more than females (24%). CONCLUSION: The emergence of XDR S. typhi with high level of resistance is quite alarming. With inadequate treatments options, the present situation calls for immediate effective preventive measures including food and water safety, improved sanitation, public awareness sessions and typhoid vaccination campaigns. Published by Elsevier Ltd. 2022-03 2022-02-28 /pmc/articles/PMC8884783/ http://dx.doi.org/10.1016/j.ijid.2021.12.010 Text en Copyright © 2021 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Op01.09 (1017)
Khan, M.
Tu-Zahra, F.
Gul, A.
Saleem, M.Z.
Riaz, M.
Gul, W.
Extensively Drug-Resistant Salmonella enterica serovar Typhi in Pediatric population during CoVID-19 Pandemic
title Extensively Drug-Resistant Salmonella enterica serovar Typhi in Pediatric population during CoVID-19 Pandemic
title_full Extensively Drug-Resistant Salmonella enterica serovar Typhi in Pediatric population during CoVID-19 Pandemic
title_fullStr Extensively Drug-Resistant Salmonella enterica serovar Typhi in Pediatric population during CoVID-19 Pandemic
title_full_unstemmed Extensively Drug-Resistant Salmonella enterica serovar Typhi in Pediatric population during CoVID-19 Pandemic
title_short Extensively Drug-Resistant Salmonella enterica serovar Typhi in Pediatric population during CoVID-19 Pandemic
title_sort extensively drug-resistant salmonella enterica serovar typhi in pediatric population during covid-19 pandemic
topic Op01.09 (1017)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884783/
http://dx.doi.org/10.1016/j.ijid.2021.12.010
work_keys_str_mv AT khanm extensivelydrugresistantsalmonellaentericaserovartyphiinpediatricpopulationduringcovid19pandemic
AT tuzahraf extensivelydrugresistantsalmonellaentericaserovartyphiinpediatricpopulationduringcovid19pandemic
AT gula extensivelydrugresistantsalmonellaentericaserovartyphiinpediatricpopulationduringcovid19pandemic
AT saleemmz extensivelydrugresistantsalmonellaentericaserovartyphiinpediatricpopulationduringcovid19pandemic
AT riazm extensivelydrugresistantsalmonellaentericaserovartyphiinpediatricpopulationduringcovid19pandemic
AT gulw extensivelydrugresistantsalmonellaentericaserovartyphiinpediatricpopulationduringcovid19pandemic